Zobrazeno 1 - 10
of 259
pro vyhledávání: '"YeoungJee Cho"'
Autor:
Josephine S. F. Chow, Neil Boudville, Yeoungjee Cho, Suetonia Palmer, Elaine M. Pascoe, Carmel M. Hawley, Donna M. Reidlinger, Laura E. Hickey, Ruth Stastny, Andrea Valks, Liza Vergara, Ramya Movva, Charani Kiriwandeniya, Hayley Candler, Gabor Mihala, Bernadette Buisman, Keri-Lu Equinox, Ana E. Figueiredo, Trudi Fuge, Kirsten Howard, Martin Howell, Allison Jaure, Matthew D. Jose, Anna Lee, Susana S. Miguel, Jo-anne Moodie, Thu T. Nguyen, Geraldine Pinlac, Annie Reynolds, Walaa W. M. Saweirs, Genevieve Z. Steiner-Lim, Bronwen TeWhare, Melinda Tomlins, Megan Upjohn, David Voss, Rachael C. Walker, Joanne Wilson, David W. Johnson
Publikováno v:
Trials, Vol 24, Iss 1, Pp 1-16 (2023)
Abstract Background Peritoneal dialysis (PD)-related infections, such as peritonitis, exit site, and tunnel infections, substantially impair the sustainability of PD. Accordingly, PD-related infection is the top-priority research outcome for patients
Externí odkaz:
https://doaj.org/article/1579c83aac2441a5936bcb89799e605f
Autor:
Karine Manera, David Johnson, Jonathan Craig, Saraladevi Naicker, Chandana Guha, Jeffrey Perl, Angela Yee-Moon Wang, Jie Dong, Yeoungjee Cho, Martin Wilkie, Edwina Brown, Roberto Pecoits-Filho, Jenny Shen, Allison Jauré, Benedicta Yudianto, Tony Dunning, Rajnish Mehrotra, Nicole Scholes-Robertson
Publikováno v:
BMJ Open, Vol 14, Iss 3 (2024)
Objectives Peritoneal dialysis (PD) allows patients increased autonomy and flexibility; however, both infectious and non-infectious complications may lead to technique failure, which shortens treatment longevity. Maintaining patients on PD remains a
Externí odkaz:
https://doaj.org/article/49665aaec5b8491d80c099de7bb353c5
Autor:
Melissa S. Cheetham, Yeoungjee Cho, Rathika Krishnasamy, Arsh K. Jain, Neil Boudville, David W. Johnson, Louis L. Huang
Publikováno v:
Kidney International Reports, Vol 7, Iss 2, Pp 165-176 (2022)
Incremental peritoneal dialysis (PD), defined as less than “standard dose” PD prescription, has a number of possible benefits, including better preservation of residual kidney function (RKF), reduced risk of peritonitis, lower peritoneal glucose
Externí odkaz:
https://doaj.org/article/501207c47b334d429e038d7fd5ea97dc
Autor:
Tahira Scott, Isabelle Ethier, Carmel Hawley, Elaine M. Pascoe, Andrea K. Viecelli, Arnold Ng, Yeoungjee Cho, David W. Johnson
Publikováno v:
BMC Nephrology, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract Background Cardiovascular disease is a leading cause of mortality in kidney failure (KF). Patients with KF from atheroembolic disease are at higher risk of cardiovascular disease than other causes of KF. This study aimed to determine surviva
Externí odkaz:
https://doaj.org/article/e19b999fb9f74275810c030eb5a56b7e
Autor:
Nicole Evangelidis, Benedicte Sautenet, Magdalena Madero, Allison Tong, Gloria Ashuntantang, Laura Cortes Sanabria, Ian H. de Boer, Samuel Fung, Daniel Gallego, Andrew S. Levey, Adeera Levin, Eduardo Lorca, Ikechi G. Okpechi, Patrick Rossignol, Laura Sola, Tim Usherwood, David C. Wheeler, Yeoungjee Cho, Martin Howell, Chandana Guha, Nicole Scholes-Robertson, Katherine Widders, Andrea Matus Gonzalez, Armando Teixeira-Pinto, Andrea K. Viecelli, Amelie Bernier-Jean, Samaya Anumudu, Louese Dunn, Martin Wilkie, Jonathan C. Craig, on behalf of the SONG-CKD Investigators
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-8 (2021)
Abstract Background Globally, over 1.2 million people die from chronic kidney disease (CKD) every year. Patients with CKD are up to 10 times more likely to die prematurely than progress to kidney failure requiring kidney replacement therapy. The burd
Externí odkaz:
https://doaj.org/article/5c1520d43d134097835d130e24af59b3
Autor:
Laura Robison, Yeoungjee Cho, Andrea K. Viecelli, David W. Johnson, Carmel M. Hawley, Andrea Valks, Peta-Anne Paul-Brent, Ruth Stastny, Julie Varghese, Charani Kiriwandeniya, Elaine M. Pascoe, Liza A. Vergara, Magid A. Fahim, Neil Boudville, Rathika Krishnasamy, Donna Reidlinger, on behalf of the Australasian Kidney Trials Network
Publikováno v:
Trials, Vol 22, Iss 1, Pp 1-9 (2021)
Abstract The unprecedented demand placed on healthcare systems from the COVID-19 pandemic has forced a reassessment of clinical trial conduct and feasibility. Consequently, the Australasian Kidney Trials Network (AKTN), an established collaborative r
Externí odkaz:
https://doaj.org/article/46c368d2f3dc4ad396f4ecb7a4d843c9
Autor:
Gregory J. Wilson, Yeoungjee Cho, Armando Teixiera-Pinto, Nicole Isbel, Scott Campbell, Carmel Hawley, David W. Johnson
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-9 (2019)
Abstract Background Membranoproliferative glomerulonephritis (MPGN) is an uncommon cause of end stage kidney disease (ESKD) and the clinical outcomes of patients with MPGN who commence kidney replacement therapy have not been comprehensively studied.
Externí odkaz:
https://doaj.org/article/9f34c59a80bb4f199bc15bb774311396
Autor:
Juan Pei, Yeoungjee Cho, Yong Pey See, Elaine M Pascoe, Andrea K Viecelli, Ross S Francis, Carolyn van Eps, Nicole M Isbel, Scott B Campbell, Philip A Clayton, Jeremy Chapman, Michael Collins, Wai Lim, Wen Tang, Germaine Wong, Carmel M Hawley, David W Johnson
Publikováno v:
PLoS ONE, Vol 16, Iss 3, p e0249000 (2021)
BackgroundThe need for kidney transplantation drives efforts to expand organ donation. The decision to accept organs from donors with acute kidney injury (AKI) can result in a clinical dilemma in the context of conflicting reports from published lite
Externí odkaz:
https://doaj.org/article/15d3023a1b6944479f947178c306b559
Autor:
Patrizia Natale, Elyssa Hannan, Bénédicte Sautenet, Angela Ju, Ronald D Perrone, Eva Burnette, Niek Casteleijn, Arlene Chapman, Sarah Eastty, Ron Gansevoort, Marie Hogan, Shigeo Horie, Bertrand Knebelmann, Richard Lee, Reem A Mustafa, Richard Sandford, Amanda Baumgart, Allison Tong, Giovanni F M Strippoli, Jonathan C Craig, Gopala K Rangan, Yeoungjee Cho
Publikováno v:
PLoS ONE, Vol 16, Iss 5, p e0252479 (2021)
Pain is a common symptom in people with autosomal dominant polycystic kidney disease (ADPKD), but it is assessed and reported inconsistently in research, and the validity of the measures remain uncertain. The aim of this study was to identify the cha
Externí odkaz:
https://doaj.org/article/80fcdff10bca4717a5af9c1ac2f27e80
Autor:
Angela Ju, Allison Tong, Armando Teixeira-Pinto, David Johnson, Jonathan Craig, Martin Howell, Ron T Gansevoort, Talia Gutman, Karine E Manera, Peter Kerr, Gopala K Rangan, Curie Ahn, Tess Harris, Charlotte Logeman, Yeoungjee Cho, Benedicte Sautenet, Albert Ong, Arlene Chapman, Helen Coolican, Juliana Tze-Wah Kao, Ronald Perrone, Vincent Torres, Kevin Fowler, York Pei, Jessica Ryan, Andrea Viecelli, Clair Geneste, Hyunsuk Kim, Yaerim Kim, Gayathri Parasivam
Publikováno v:
BMJ Open, Vol 10, Iss 10 (2020)
Background and objectives Presymptomatic testing is available for early diagnosis of hereditary autosomal dominant polycystic kidney disease (ADPKD). However, the complex ethical and psychosocial implications can make decision-making challenging and
Externí odkaz:
https://doaj.org/article/e8d547dcad65403eb9a4e532022791fc